Vote Scores
Filings read through

How funds voted at NewAmsterdam Pharma Company N.V.

Ticker
NAMS
SEC company number
1936258
Filers reporting
273, year to 30 June 2026
Latest meeting on file
Meetings on file
3

In the year to 30 June 2026, 273 filers on Form N-PX reported votes at NewAmsterdam Pharma Company N.V.. The votes fall in one meeting. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 709 marks to the ballot items, each with or against management. 82.2% of the marks are with management.

On say-on-pay, 57 of the 248 reporting filers that marked the item voted against management. This is 23.0% of the filers. Of the reported shares, 5.3% went against management. The median of the 3,799 companies on this site with a say-on-pay item is 6.6% of filers and 2.9% of reported shares.

At the meeting of 2 Jun 2026, 29 fund families have a say-on-pay position with management and 7 have a position against management.

By filers reporting in the year to 30 June 2026, NewAmsterdam Pharma Company N.V. was number 2,110 of 11,972 companies with a page and votes in that year. The number of filers reporting at NewAmsterdam Pharma Company N.V. rose by 51.7% from the year to 30 June 2025 to the year to 30 June 2026. At the companies on this site with filers in both years, the total of filers reporting rose by 6.0%. In all seasons on file, category DIRECTOR ELECTIONS is 23.6% of the vote records at NewAmsterdam Pharma Company N.V.. At all companies on this site, it is 52.2%.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 2 Jun 2026

268 filers reported votes at this meeting in the year to 30 June 2026. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

  1. Item 1: Director elections

    2 nominees. 80.6% of the reported votes are for. 36 filers withheld from or voted against at least one nominee.

    275 vote records from 94 filers. 1 of the 92 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 29 fund families
    • For 20
    • Split or no vote 9
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    374 vote records from 266 filers. 57 of the 248 filers that marked the item voted against management. 18 filers gave no management mark.

    • Positions of 36 fund families
    • For 29
    • Against 7
    • Against management 7
  3. Item 3: Audit-related items (auditor ratification)

    262 vote records from 94 filers. 1 of the 92 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 29 fund families
    • For 29
  4. Item 4: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    275 vote records from 93 filers. 64 of the 91 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 29 fund families
    • For 4
    • Against 25
    • Against management 25
  5. Item 5: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    134 vote records from 88 filers. 2 of the 86 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 28 fund families
    • For 28
  6. Item 6: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    262 vote records from 93 filers. 1 of the 91 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 29 fund families
    • For 29
  7. Item 7: OTHER: management items

    The company's items in this category are shown together, because filers word and number them differently.

    17 vote records from 9 filers. 0 of the 9 filers that marked the item voted against management.

    • Positions of one fund family
    • For 1

Positions of the fund families at the meeting of 2 Jun 2026

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at NewAmsterdam Pharma Company N.V., meeting of 2 Jun 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund familySay-on-pay
AllianceBernsteinFor
AllspringFor
American CenturyAgainst, against management
BlackRock and iSharesFor
BNY MellonAgainst, against management
Brighthouse FundsFor
Capital Group and American FundsFor
Charles SchwabFor
Columbia ThreadneedleFor
EquitableFor
Federated HermesFor
FidelityFor
First TrustFor
Franklin TempletonFor
Global XAgainst, against management
Goldman SachsFor
Harbor FundsFor
Hartford FundsFor
InvescoAgainst, against management
J.P. MorganFor
Janus HendersonFor
John Hancock and ManulifeFor
Lord AbbettFor
Morgan Stanley, Eaton Vance and CalvertFor
Natixis and Loomis SaylesFor
Northern Trust and FlexSharesFor
Nuveen and TIAAFor
Pacific Life fundsFor
PGIM and PrudentialAgainst, against management
PrincipalFor
ProShares and ProFundsFor
Russell InvestmentsAgainst, against management
SEIAgainst, against management
State Street and SPDRFor
VanguardFor
Victory CapitalFor

Every meeting on file

Meetings of NewAmsterdam Pharma Company N.V., from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 2026268723.0%
year to 30 June 202517962.5%
year to 30 June 2024144not reported

Say-on-pay, season by season

Say-on-pay at NewAmsterdam Pharma Company N.V.: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 202627323.0%5.3%
year to 30 June 20251802.5%0.6%
year to 30 June 202415not reportednot reported
NewAmsterdam Pharma Company N.V. and the median of companies on this site, year to 30 June 2026
Say-on-payThis companyMedian of companies on this site
Filers against management23.0%6.6%
Reported shares against management5.3%2.9%

The median covers 3,799 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at NewAmsterdam Pharma Company N.V. by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS70523.6%
SECTION 14A SAY-ON-PAY VOTES84628.3%
AUDIT-RELATED46315.5%
CAPITAL STRUCTURE37612.6%
COMPENSATION1344.5%
CORPORATE GOVERNANCE45115.1%
OTHER170.6%

The record at the SEC

Each link loaded on .

Embed this card on your site

Copy this code into your page. The card shows the figures above with their source. A line under the card links to this page.

How embedding works. It is free. Keep the link in the card and the link line under it.

Cite this page

Vote Scores. How funds voted at NewAmsterdam Pharma Company N.V.. https://votescores.com/company/newamsterdam-pharma-company-n-v/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of NewAmsterdam Pharma Company N.V. are on file?
3 meetings are on file, from 5 Jun 2024 to 2 Jun 2026. 2 meetings have 20 or more reporting filers and have their own page.
Did filers report proposals from security holders at NewAmsterdam Pharma Company N.V.?
Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2026. The ballot shows the items that filers did report.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. NewAmsterdam Pharma Company N.V. reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list NewAmsterdam Pharma Company N.V., grouped by company. The name is the most common spelling among filers. The ticker and the SEC company number come from the SEC company tickers file, matched on the exact name. The filers wrote the filings. Filings read through .